[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336238-105":59,"doc-detail-336238-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effect-of-radiotherapy-on-activating-the-pyroptotic-cell-death-pathway-in-breast-cancer-patients-the-role-of-serum-gsdmd-ct-nlrp3-and-il-18","Effect of Radiotherapy on Activating the Pyroptotic Cell Death Pathway in Breast Cancer Patients - The Role of Serum GSDMD-CT, NLRP3 and IL-18","","Breast cancer remains the leading malignancy among women, and radioresistance contributes to radiotherapy failure. Ionizing radiation can trigger pyroptosis, an inflammation-linked programmed cell death associated with cellular ROS. The study assessed whether serum GSDMD-CT, NLRP3, and IL-18 predict radiotherapy-induced pyroptotic mechanisms in 70 female participants. Women with breast cancer received 44 Gy over 16 days, biomarkers were measured by ELISA before and after treatment, and controls provided baseline comparison.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effect-of-radiotherapy-on-activating-the-pyroptotic-cell-death-pathway-in-breast-cancer-patients-the-role-of-serum-gsdmd-ct-nlrp3-and-il-18/336238/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effect-of-radiotherapy-on-activating-the-pyroptotic-cell-death-pathway-in-breast-cancer-patients-the-role-of-serum-gsdmd-ct-nlrp3-and-il-18/336238.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the study?","Question",{"text":112,"@type":113},"To investigate the role of serum GSDMD-CT, NLRP3, and IL-18 as predictors of radiotherapy-induced pyroptotic cell death in breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants grouped and treated?",{"text":117,"@type":113},"Seventy female participants were divided into 40 breast cancer patients receiving radiotherapy and a control group of 30 healthy volunteers. Patients received 44 Gy over 16 days in five daily fractions.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biomarkers were measured and what did the results show?",{"text":121,"@type":113},"Serum pyroptosis biomarkers IL-18, NLRP3, and GSDMD-CT were measured using ELISA before and after radiotherapy. Results showed a significant increase in all three markers after treatment compared with baseline.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336238,1790381442,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  \nEditorial Process: Submission:06/06/2023 Acceptance:02/11/2024  \nEffect of Radiotherapy on Activating the Pyroptotic Cell Death Pathway in Breast Cancer Patients: The Role of Serum GSDMD-CT, NLRP3 and IL-18  \nTaha I. Mahmoud Hewala1, Sanaa A. El-Benhawy1, Yasmine Nagy Elwany2 *, Hossam Elmasry3, Ayman Elrhawy4  \nAbstract  \nBackground: Breast cancer (BC) is the most common form of cancer among women and the second leading cause of cancer-related death worldwide. Several malignancies can be successfully treated with radiation (RT), although radioresistance is still a major contributor to radiotherapy failure. Ionizing radiation (IR) induces pyroptosis in cancer cells. Pyroptosis is a designed method of death connected to routine immunity and directly related to the body ROS content. Objective for the study: The aim of this work was to investigate the role of serum GSDMD-CT, nucleotidebinding domain and leucine-rich-repeat-containing family pyrin 3 (NLRP3) and IL-18 as predictors of pyroptotic cell death mechanism induced by radiotherapy in breast cancer patients. Subjects and Methods: The 70 female participants in this study were divided into two groups: Group (I): 40 breast cancer patients treated with radiotherapy. Group (II): a control group of 30 healthy volunteers with similar ages and sex. Patients with breast cancer received radiation, with a dose of 44 Gray administered over the course of 16 days in five daily fractions of 2.75 Gray each. Two blood samples were taken from breast cancer patients: one before radiotherapy and the other after radiotherapy. While one blood sample was taken from healthy controls. The levels of the circulating pyroptosis biomarkers IL-18, NLRP3, and GSDMD-CT were measured using the ELISA method. Results: Our results showed that, there was a significant increase in serum pyroptosis markers GSDMD-CT, NLRP3 and IL-18 in BC Patients after RT when compared to before radiotherapy.Conclusion: Radiotherapy induced pyroptosis in breast cancer patients as a new cell death mechanism. GSDMD-CT, NLRP3 and IL-18 are biomarkers of pyroptosis that significantly increased post irradiation highlighting enhanced ROS and pyroptosis induction.  \nKeywords: Breast cancer-Radiotherapy-Pyroptosis-GSDMD-CT-NLRP3  \nAsian Pac J Cancer Prev, 25 (2), 447-452  \nIntroduction  \nThe most common malignancy among women worldwide is breast cancer [1] . Breast cancer treatment is multimodal and includes surgery, radiation, chemotherapy, and hormonal therapy. In patients with primary breast cancer following breast conserving surgery and those with locally advanced breast cancer following mastectomy, radiotherapy is used [2] .  \nRadiotherapy is a common modality for tumor treatment in which a therapeutic dose of ionizing radiation (IR) is delivered to the cancer cells. This radiation damages cancerous tissue, with the wanted result being cell death. The dose of radiation is determined by the oncologist, and be contingent on the size, phase and site of the tumor, and the use of any other treatment moods [3] . Radiotherapy  \nmay also be used as part of adjuvant treatment when it is assumed after surgery to the area of the tumor bed and local lymph nodes, to kill microscopic cancer cells that may have escaped surgery. Radiotherapy can decrease the hazard of recurrence by 50-66% and is measured critical when breast cancer is treated by breast conservative surgery (breast conservation therapy) [4] .  \nMany cancers are treated with radiotherapy; however radioresistance continues to be a major factor in radiotherapy failure. High-energy ionizing radiation is used in radiotherapy to allow DNA double-strand breaks that lead to cell cycle arrest, senescence, and a number of cell death processes like apoptosis, necrosis, autophagy, and mitotic catastrophe [5, 6] . Developed resistance to apoptosis is a marker of malignancy. Thus, induction of non-apoptotic forms of measured cell death has become  \n1Radiation Sciences Departme","cbCaii5Ll0d1ibjL","https://ap.wps.com/l/cbCaii5Ll0d1ibjL","pdf",594266,"English","# Abstract\n# Introduction\n## Radiotherapy in breast cancer\n## Cell death mechanisms and pyroptosis","[{\"question\":\"What was the objective of the study?\",\"answer\":\"To investigate the role of serum GSDMD-CT, NLRP3, and IL-18 as predictors of radiotherapy-induced pyroptotic cell death in breast cancer patients.\"},{\"question\":\"How were participants grouped and treated?\",\"answer\":\"Seventy female participants were divided into 40 breast cancer patients receiving radiotherapy and a control group of 30 healthy volunteers. Patients received 44 Gy over 16 days in five daily fractions.\"},{\"question\":\"Which biomarkers were measured and what did the results show?\",\"answer\":\"Serum pyroptosis biomarkers IL-18, NLRP3, and GSDMD-CT were measured using ELISA before and after radiotherapy. Results showed a significant increase in all three markers after treatment compared with baseline.\"}]","Effect of Radiotherapy on Activating the Pyroptotic Cell Death Pathway in Breast Cancer Patients - The Role of Serum GSDMD-CT, NLRP3 and IL-18 | PDF",1790014222,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/147cd26b3bc2750245115ab3ad6ef34c.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7ca9e5615787c7e794c23e6456bac22.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa805d62c8a11e3ef250363a6e4a6cde.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7005af90eb84bd02368cf6fd624e961.webp",980,1385]